Doctors’ Roles and Responsibilities

Earlier this month, I gave a presentation to about 65 residents and other doctors at the Queens Hospital Center in Jamaica, New York. The topic? “Roles in Patient-Doctor Relationships: Seeing Both Sides”

Over the next several posts, various aspects of that talk will be highlighted:

      • Doctors’ Roles and Responsibilities (including doctor morale)
      • Patients’ Roles and Responsibilities (and what doctors wish patients knew)
      • Stages of Patient Frustration and Satisfaction
      • Doctor Actions Improving Patient Relationships
      • Patient Actions Improving Doctor Relationships
      • We’re Not There Yet on Doctor-Patient Relationships

Doctors typically have the roles and responsibilities highlighted in this image.

Read more

Be Careful with OTC Drugs

For many people, there is a misconception that over-the-counter (OTC) drugs are always safer than prescription drugs. And that simply is not true.

Consider these observations from AARP:

“If the good news is that over-the-counter pain killers such as acetaminophen, ibuprofen, and naproxen won’t put you at risk for addiction issues like prescription opioids or narcotics can, the less good news is that no pain pill comes without the potential for problems, says Nitin Sekhri, medical director of pain management at Westchester Medical Center in Valhalla, N.Y.”

Read more

Cancer Research Institute Conference Video

In June, the Cancer Research Institute held its annual cancer awareness conference. Complete with an excellent video, which is shown below.

As it notes at YouTube:

“Our panel of immunotherapy experts discusses the latest cancer immunotherapy advances featured at the world’s largest oncology conference—the 2018 annual meeting of the American Society of Clinical Oncology (ASCO)—with topics including combination immunotherapy, biomarker development, CAR T cell therapies, and new approaches to immune-based cancer treatment.”

Read more

New Cancer Drug Approved

Yet, researchers are working quite hard. And billions of dollars are being spent.

Quite recently, the FDA approved a new and VERY expensive cancer drug. As CNN reports:

“Vitrakvi is the first medication developed specifically to target tumors based on gene mutations, not their location in the body.”

Read more